However, the activity of pDC has been reported to be inhibited in most tumor microenvironments and associated with poor prognosis in a variety of tumors, which may result from the ability of pDCs to promote the expansion of Treg cells in an inducible T cell co-stimulator ligand (ICOSL)-dependent manner 43. The gene discussed is PDC; the disease is neoplasm.